Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DD9NG5
|
|||
| Drug Name |
SHP-627
|
|||
| Synonyms |
FT011; 1001288-58-9; FT-011; UNII-C6V7ZU2NPR; C6V7ZU2NPR; 2-(3-Methoxy-4-propargyloxycinnamoyl)aminobenzoic acid; 2-[[(E)-3-(3-methoxy-4-prop-2-ynoxyphenyl)prop-2-enoyl]amino]benzoic acid; Benzoic acid, 2-(((2E)-3-(3-methoxy-4-(2-propyn-1-yloxy)phenyl)-1-oxo-2-propen-1-yl)amino)-; Benzoic acid, 2-[[(2E)-3-[3-methoxy-4-(2-propyn-1-yloxy)phenyl]-1-oxo-2-propen-1-yl]amino]-; SCHEMBL1590608; SCHEMBL1590611; CHEMBL1075834; FT 011; ZINC49050436; CS-5842; SB16798; HY-100495; (E)-2-[[3-(3-methoxy-4-(prop-2-ynyloxy)phenyl)-1-oxo-2-propenyl]amino]benzoic acid; (E)-2-[[3-(3-methoxy-4-propargyloxyphenyl)-1-oxo-2-propenyl]amino]benzoic acid; 2-(((2E)-3-(3-Methoxy-4-(2-propyn-1-yloxy)phenyl)-1-oxo-2-propen-1-yl)amino)benzoic acid
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Cardiac arrest [ICD-11: MC82] | Preclinical | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C20H17NO5
|
|||
| Canonical SMILES |
COC1=C(C=CC(=C1)C=CC(=O)NC2=CC=CC=C2C(=O)O)OCC#C
|
|||
| InChI |
1S/C20H17NO5/c1-3-12-26-17-10-8-14(13-18(17)25-2)9-11-19(22)21-16-7-5-4-6-15(16)20(23)24/h1,4-11,13H,12H2,2H3,(H,21,22)(H,23,24)/b11-9+
|
|||
| InChIKey |
UIWZIDIJCUEOMT-PKNBQFBNSA-N
|
|||
| CAS Number |
CAS 1001288-58-9
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Transforming growth factor beta (TGFB) | Target Info | Inhibitor | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs and Targets in Fibrosis. Front Pharmacol. 2017 Nov 23;8:855. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.